Results of Pivotal Phase 2 Clinical Trial of Tagraxofusp (SL-401) in Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)


Conference Paper

Full Text

Duke Authors

Cited Authors

  • Pemmaraju, N; Lane, AA; Sweet, KL; Stein, AS; Vasu, S; Blum, W; Rizzieri, DA; Wang, ES; Duvic, M; Spence, S; Shemesh, S; Brooks, C; Bergstein, I; Chen, J; Dunn, V; McDonald, P; Sloan, JM; Lancet, JE; Kantarjian, HM; Konopleva, MY

Published Date

  • November 29, 2018

Published In

Volume / Issue

  • 132 /

Published By


  • 4

Electronic International Standard Serial Number (EISSN)

  • 1528-0020

International Standard Serial Number (ISSN)

  • 0006-4971

Digital Object Identifier (DOI)

  • 10.1182/blood-2018-99-118966

Conference Name

  • 60th Annual Meeting of the American-Society-of-Hematology (ASH)

Conference Location

  • San Diego, CA

Conference Start Date

  • December 1, 2018

Conference End Date

  • December 4, 2018